journal article·2023-10-25Open access

In Situ Photo-crosslinkable Hyaluronic Acid/Gelatin Hydrogel for Local Nitric Oxide Delivery

Daniele M. Catori, Laura C. E. da Silva, Matheus F. de Oliveira, Grace H. Nguyen, Joseph C. Moses, Elizabeth J. Brisbois, Hitesh Handa, Marcelo G. de Oliveira

ACS Applied Materials & Interfaces· Volume 15· Issue 42

Abstract

An increasing number of studies have shown that the local release of nitric oxide (NO) from hydrogels stimulates tissue regeneration by modulating cell proliferation, angiogenesis, and inflammation. The potential biomedical uses of NO-releasing hydrogels can be expanded by enabling their application in a fluid state, followed by controlled gelation triggered by an external factor. In this study, we engineered a hydrogel composed of methacrylated hyaluronic acid (HAGMA) and thiolated gelatin (GELSH) with the capacity for in situ photo-cross-linking, coupled with localized NO release. To ensure a gradual and sustained NO release, we charged the hydrogels with poly( l -lactic- co -glycolic acid) (PLGA) nanoparticles functionalized with S -nitrosoglutathione (GSNO), safeguarding SNO group integrity during photo-cross-linking. The formation of thiol–ene bonds via the reaction between GELSH’s thiol groups and HAGMA’s vinyl groups substantially accelerated gelation (by a factor of 6) and increased the elastic modulus of hydrated hydrogels (by 1.9–2.4 times). HAGMA/GELSH hydrogels consistently released NO over a 14 day duration, with the release of NO depending on the hydrogels’ equilibrium swelling degree, determined by the GELSH-to-HAGMA ratio. Biocompatibility assessments confirmed the suitability of these hydrogels for biological applications as they display low cytotoxicity and stimulated fibroblast adhesion and proliferation. In conclusion, in situ photo-cross-linkable HAGMA/GELSH hydrogels, loaded with PLGA-GSNO nanoparticles, present a promising avenue for achieving localized and sustained NO delivery in tissue regeneration applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Hydrogels: synthesis, properties, applications · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Chemistry, University of Campinas, UNICAMP, Campinas 13083-970, São Paulo, Brazil

School of Chemical, Materials and Biomedical Engineering, College of Engineering, University of Georgia, Athens 30602, Georgia, United States

Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens 30602, Georgia, United States

Funding

National Heart, Lung, and Blood Institute · Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico · Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo · Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

References (53)

Show source-provided references
1. 10.1016/j.jacc.2013.03.07010.1016/j.jacc.2013.03.070 ↗
2. 10.1007/s10856-013-4973-710.1007/s10856-013-4973-7 ↗
3. 10.1016/j.actbio.2018.05.02510.1016/j.actbio.2018.05.025 ↗
4. 10.1002/term.304610.1002/term.3046 ↗
5. 10.1016/j.niox.2020.03.00210.1016/j.niox.2020.03.002 ↗
6. 10.1016/j.jcis.2022.08.11310.1016/j.jcis.2022.08.113 ↗
7. 10.1021/acsbiomaterials.1c0112110.1021/acsbiomaterials.1c01121 ↗
8. 10.1016/j.engreg.2020.10.00110.1016/j.engreg.2020.10.001 ↗
9. 10.1016/j.ijbiomac.2019.11.06610.1016/j.ijbiomac.2019.11.066 ↗
10. 10.3390/ijms1704041110.3390/ijms17040411 ↗
11. 10.17221/1930-VETMED10.17221/1930-VETMED ↗
12. 10.1016/j.actbio.2013.10.00510.1016/j.actbio.2013.10.005 ↗
13. 10.1080/00914037.2016.120182810.1080/00914037.2016.1201828 ↗
14. 10.1016/j.biomaterials.2004.02.06710.1016/j.biomaterials.2004.02.067 ↗
15. 10.1021/acs.chemrev.0c0092310.1021/acs.chemrev.0c00923 ↗
16. 10.1016/j.addr.2018.03.00710.1016/j.addr.2018.03.007 ↗
17. 10.1038/srep2997810.1038/srep29978 ↗
18. 10.18063/ijb.v7i3.36710.18063/ijb.v7i3.367 ↗
19. 10.1002/term.284110.1002/term.2841 ↗
20. 10.1016/j.ijbiomac.2018.07.15310.1016/j.ijbiomac.2018.07.153 ↗
21. 10.1111/bcpt.1258810.1111/bcpt.12588 ↗
22. 10.1016/j.niox.2019.01.00210.1016/j.niox.2019.01.002 ↗
23. 10.1590/s0103-5053201000100001310.1590/s0103-50532010001000013 ↗
24. 10.1021/jo900033c10.1021/jo900033c ↗
25. 10.1016/j.eurpolymj.2011.02.01510.1016/j.eurpolymj.2011.02.015 ↗
26. 10.3390/pharmaceutics1207061810.3390/pharmaceutics12070618 ↗
27. 10.1016/j.niox.2022.01.00610.1016/j.niox.2022.01.006 ↗
28. International Organization for Standardization. Biological Evaluation of Medical Devices─Part 5: Tests for In Vitro Cytotoxicity; ISO 10993–5:2009, 2009;
29. 10.1007/s40883-019-00115-410.1007/s40883-019-00115-4 ↗
30. 10.1039/C5RA27865A10.1039/C5RA27865A ↗
31. 10.1134/S106816202104019110.1134/S1068162021040191 ↗
32. Silverstein R. M. · 2005
33. 10.1021/cr000040l10.1021/cr000040l ↗
34. 10.1016/j.actbio.2019.07.03510.1016/j.actbio.2019.07.035 ↗
35. 10.1016/j.reactfunctpolym.2018.06.01010.1016/j.reactfunctpolym.2018.06.010 ↗
36. 10.1016/j.eurpolymj.2016.02.02510.1016/j.eurpolymj.2016.02.025 ↗
37. 10.3390/polym1101000510.3390/polym11010005 ↗
38. Bruice P. Y. · 2004 · 1
39. 10.3390/mi1305078010.3390/mi13050780 ↗
40. 10.1080/21691401.2017.134592410.1080/21691401.2017.1345924 ↗
41. 10.3390/polym303137710.3390/polym3031377 ↗
42. 10.1021/cr050247k10.1021/cr050247k ↗
43. 10.3390/polym1405099310.3390/polym14050993 ↗
44. Fukuto J. M. · 2000 · 2310.1016/B978-012370420-7/50003-4 ↗
45. 10.1016/j.polymdegradstab.2016.10.01710.1016/j.polymdegradstab.2016.10.017 ↗
46. 10.1016/j.niox.2019.04.01110.1016/j.niox.2019.04.011 ↗
47. 10.1016/j.freeradbiomed.2008.03.02010.1016/j.freeradbiomed.2008.03.020 ↗
48. 10.1038/sj.bjp.070532410.1038/sj.bjp.0705324 ↗
49. 10.1088/1748-605X/ab954e10.1088/1748-605X/ab954e ↗
50. 10.1039/C9PY01021A10.1039/C9PY01021A ↗
51. 10.1002/cm.2004110.1002/cm.20041 ↗
52. 10.1016/j.jmbbm.2012.10.00110.1016/j.jmbbm.2012.10.001 ↗
53. 10.1016/j.freeradbiomed.2008.03.02010.1016/j.freeradbiomed.2008.03.020 ↗